Advanced Enzyme reports strong financial performance for September 2025 quarter

Advanced Enzyme Technologies announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2025, with total consolidated income reaching INR 3,895.76 million for the six months, leading to a profit before tax of INR 1,144.41 million. The consolidated net profit for the period stood at INR 851.73 million. For the standalone results, total income was INR 2,977.03 million for the six months, with a profit before tax of INR 1,110.15 million and a net profit of INR 962.63 million.

The company's board of directors approved these results, which include the performance of several subsidiaries, such as Advanced Bio-Agro Tech Limited and Advanced Enzymes USA, Inc. The consolidated financial results also incorporate the interim results of four subsidiaries that contribute significantly to assets (INR 1,954.23 million), revenues (INR 1,133.05 million for the half-year), and net profit (INR 91.72 million for the half-year). The company also noted the incorporation of a new wholly-owned subsidiary, Advanced Nutrazyme Private Limited, effective July 4, 2025, to focus on nutrition and wellness products.

These financial statements, prepared in accordance with Indian Accounting Standards, were reviewed by MSKA & Associates, Chartered Accountants, who issued an unmodified conclusion. The board also declared an interim dividend of INR 4/- per equity share during the quarter, with a final dividend of INR 1.20/- for the fiscal year 2024-25, paid on August 5, 2025.